Tracerlab: Scientific collaboration
We, as Tracerlab, are looking to collaborate with medical researchers, preferably educational institutions, who are looking for the synthetic development and initial in vitro validation of PET/optical/MRI tracers.
Collaborate with medical researchers, who are looking for the synthetic development and initial in vitro validation of PET/optical/MRI tracers.
What we're looking for
We, as Tracerlab, are looking to collaborate with medical researchers, preferably educational institutions, who are looking for the synthetic development and initial in vitro validation of PET/optical/MRI tracers. Typically, we’re looking to collaborate with someone who is looking to visualize a process/receptor/enzyme/etc, knows from literature a good chemical entity that could be used (enzyme inhibitor, receptor ligand, etc.) but has no idea how to make it and then modify it towards an imaging modality. Sometimes, this person is uncertain what imaging modality to use and we can help.
We’re not just looking to collaborate with medical researchers, but also with preclinical scientists looking for collaboration and students interested in BSc, MSc and PhD programs.
Expertise & Facilities
FFC Relaxometry: T1 NMRD profile acquisition using Stelar SMARtracer equipment
Meet the team
See who's involved with Tracerlab right now and who's been involved in the past.
Hugo Helbert, MsC
Ilse Welleman, MsC
Verena I. Boehmer, PhD
Friederike Reeßing, PhD
ACS Omega 2020, 5, 22071-22080
A Facile and Reproducible Synthesis of Near-Infrared Fluorescent Conjugates with Small Targeting Molecules for Microbial Infection Imaging
Friederike Reeßing, Mafalda Bispo, Marina López-Álvarez, Marleen van Oosten, Ben L. Feringa, Jan Maarten van Dijl, Wiktor Szymanski*
Chem. Eur. J. 2020, 26, 10871 –10881
Modular Medical Imaging Agents Based on Azide–Alkyne Huisgen Cycloadditions: Synthesis and Pre‐Clinical Evaluation of 18F‐Labeled PSMA‐Tracers for Prostate Cancer Imaging
Verena I. Böhmer, Wiktor Szymanski,* Keimpe-Oeds van den Berg, Chantal Mulder, Piermichele Kobauri, Hugo Helbert, Dion van den Born, Friederike Reessing, Anja Huizing,…, Gert Luurtsema, Wijnand Helfrich, Ton J. Visser, Ben L. Feringa,* Philip H. Elsinga*
Curr. Opin. Biotech. 2019, 58, 9-18
Following nanomedicine activation with magnetic resonance imaging: why, how, and what’s next?
Friederike Reeßing, Wiktor Szymanski*